Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 3/20 | 0.74 |
| ▸ | SHBG | P04278 | 3/20 | 0.66 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.66 |
| ▸ | THRB | P10828 | 1/20 | 0.66 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 5/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.52 |
| ▸ | ABCB11 | O95342 | 3/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | ESR1 | P03372 | 2/20 | 0.52 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxendolone SCHEMBL233297 | 1.00 | PGR (0.74) | PGRSHBGSERPINA6ALDH1A1SLC22A1 | |
| Oxendolone SCHEMBL12826307 | 1.00 | PGR (0.74) | PGRSHBGSERPINA6ALDH1A1SLC22A1 | |
| Oxendolone SCHEMBL10380170 | 1.00 | PGR (0.74) | PGRSHBGSERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL10380864 | 0.91 | PGR (0.66) | PGRSHBGSERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL10624478 | 0.86 | ALDH1A1 (0.72) | PGRSHBGSERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL17209910 | 0.86 | SHBG (0.72) | PGRSHBGSERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL17078378 | 0.85 | PGR (1.00) | PGRSHBGSERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL21010519 | 0.85 | PGR (1.00) | PGRSHBGSERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL4660380 | 0.85 | PGR (1.00) | PGRSHBGSERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL14870642 | 0.85 | PGR (1.00) | PGRSHBGSERPINA6ALDH1A1SLC22A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11569868-B2 | Apparatuses and methods for enhancing a reliability of power available to communicaton devices via an insulator | AT&T INTELLECTUAL PROPERTY I, L.P. (US) | 2023-01-31 | — | — | US | disclosed |
| US-20220302958-A1 | APPARATUSES AND METHODS FOR ENHANCING A RELIABILITY OF POWER AVAILABLE TO COMMUNICATON DEVICES VIA AN INSULATOR | AT&T INTELLECTUAL PROPERTY I, L.P. (US) | 2022-09-22 | — | — | US | disclosed |
| US-20220302950-A1 | APPARATUSES AND METHODS FOR FACILITATING A CONVEYANCE OF STATUS IN COMMUNICATION SYSTEMS AND NETWORKS | AT&T INTELLECTUAL PROPERTY I, L.P. (US) | 2022-09-22 | — | — | US | disclosed |
| US-20200155521-A1 | PHARMACEUTICAL COMBINATION FOR TREATMENT OF CANCER | ARQULE, INC. | 2020-05-21 | — | — | US | disclosed |
| US-7927613-B2 | Pharmaceutical co-crystal compositions | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-04-19 | — | — | US | disclosed |
| US-7790905-B2 | Pharmaceutical propylene glycol solvate compositions | MCNEIL-PPC, INC. (US) | 2010-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200155521-A1 | PHARMACEUTICAL COMBINATION FOR TREATMENT OF CANCER | TP53, KRAS, VHL | PGR 1396/4885SHBG 2973/4885SERPINA6 1328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.